Published in Am J Transplant on July 01, 2008
Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology (2010) 1.39
Towards the identification of biomarkers of transplantation tolerance. Nat Rev Immunol (2009) 0.91
Clinical transplantation tolerance. Semin Immunopathol (2011) 0.83
TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells. J Immunol (2014) 0.82
Comment on 'Tolerance versus immunosuppression: a perspective'. Am J Transplant (2009) 0.75
Tolerance--is it worth it? Cold Spring Harb Perspect Med (2014) 0.75
Response to 'Tolerance versus immunosuppression: a perspective'. Am J Transplant (2008) 0.75
Tolerance versus immunosuppression: a perspective. Am J Transplant (2008) 0.75
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med (1996) 4.41
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06
Clinical decision support systems for the practice of evidence-based medicine. J Am Med Inform Assoc (2001) 3.90
Development and acceptance of medical information systems: an historical overview. J Health Hum Resour Adm (1988) 3.76
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43
The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant (2010) 3.35
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Increasing live donor kidney transplantation: a randomized controlled trial of a home-based educational intervention. Am J Transplant (2006) 3.11
International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int (1993) 3.11
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant (2010) 3.05
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study. Am J Transplant (2007) 2.46
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation (1997) 2.46
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant (2007) 2.25
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant (2009) 2.24
Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model. J Cereb Blood Flow Metab (1989) 2.03
Sexually transmitted diseases, sexual behavior, and cocaine use in inner-city women. Am J Epidemiol (1994) 1.95
Risk factors for early readmission among veterans. Health Serv Res (1990) 1.95
FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant (2008) 1.94
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant (2012) 1.93
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results. Chest (1993) 1.89
Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis (1996) 1.84
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.78
The epidemiology of heat-related deaths, Texas--1950, 1970-79, and 1980. Am J Public Health (1983) 1.75
Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant (2008) 1.73
Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. Am J Transplant (2011) 1.69
Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma. Ann Thorac Surg (1990) 1.66
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant (2010) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant (2011) 1.60
Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation (1995) 1.59
The 'two, one, zero' decision: what to do with suboptimal deceased donor kidneys. Am J Transplant (2010) 1.58
Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant (2013) 1.57
Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. Am J Pathol (1989) 1.55
The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant (2010) 1.54
Preimplantation diagnosis of single gene disorders by two-step oocyte genetic analysis using first and second polar body. Biochem Mol Med (1997) 1.52
Lies, damn lies, and statistics: the perils of the P value. Am J Transplant (2006) 1.50
Primum non Nocere: is chronic kidney disease staging appropriate in living kidney transplant donors? Am J Transplant (2009) 1.49
Fallopian tube torsion: laparoscopic evaluation and treatment of a rare gynecological entity. J Am Board Fam Pract (2001) 1.49
The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors. Am J Transplant (2015) 1.48
Medical correlates of urinary incontinence in the elderly. Urology (1990) 1.48
Transvaginal ultrasound in patients with low beta-human chorionic gonadotropin values: how often is the study diagnostic? Ann Emerg Med (1997) 1.47
Preemptive retransplantation for BK virus nephropathy: successful outcome despite active viremia. Am J Transplant (2006) 1.47
An abasic site in DNA. Solution conformation determined by proton NMR and molecular mechanics calculations. Nucleic Acids Res (1987) 1.47
The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation (2001) 1.46
Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg (1980) 1.45
A ten year experience with cadaver kidney preservation using cryoprecipitated plasma. Am J Surg (1978) 1.44
Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant (2007) 1.44
The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant (2010) 1.43
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation (1995) 1.43
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant (2012) 1.42
Tumescent anesthesia for dermatologic surgery. Cosmetic and noncosmetic procedures. Dermatol Surg (1998) 1.42
Fetal middle-cerebral and umbilical artery flow assessments after glucose challenge test. Int J Gynaecol Obstet (1999) 1.42
Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol (1993) 1.42
Campylobacter-like organisms in association with symptomatic gastritis in children. J Pediatr (1986) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin. Circ Res (1999) 1.41
Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol (2001) 1.40
AZA/tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients. Am J Transplant (2009) 1.40
Training the novice in laparoscopy. More challenge is better. Surg Endosc (2002) 1.40
Renal failure after eating "magic" mushrooms. CMAJ (1992) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
A mobile aerosol cryotherapy device (Histofreezer) for treatment of cervical contact bleeding: a pilot study. J Obstet Gynaecol (2003) 1.39
Sonographic differential diagnosis of persistent ovarian cysts. Ultrasound Obstet Gynecol (1998) 1.38
USDA plans for BSE contingency. J Am Vet Med Assoc (1997) 1.38
Organ donation: the gift, the weight and the tyranny of good acts. Am J Transplant (2007) 1.38
Pregnancies following pre-conception diagnosis of common aneuploidies by fluorescent in-situ hybridization. Hum Reprod (1995) 1.38
Predictive value of history and physical examination in patients with suspected ectopic pregnancy. Ann Emerg Med (1999) 1.37
Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation (1998) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant (2008) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Penetration of the bladder by a perforating intrauterine contraceptive device: a sonographic diagnosis. Ultrasound Obstet Gynecol (1996) 1.32
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. Am J Transplant (2010) 1.31
A tobacco plasma membrane calmodulin-binding transporter confers Ni2+ tolerance and Pb2+ hypersensitivity in transgenic plants. Plant J (1999) 1.30
Telomere shortening in kidneys with age. J Am Soc Nephrol (2000) 1.29
Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol (1996) 1.28
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation (1996) 1.27
The regulation of expression of major histocompatibility complex products. Transplantation (1986) 1.27
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation (1999) 1.27
Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant (2013) 1.25
Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med (1992) 1.24
Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study. Am J Transplant (2013) 1.23
Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. Am J Transplant (2009) 1.21
Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches. Am J Transplant (2009) 1.19
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Expression of a truncated tobacco NtCBP4 channel in transgenic plants and disruption of the homologous Arabidopsis CNGC1 gene confer Pb2+ tolerance. Plant J (2000) 1.19
Polar body diagnosis of common aneuploidies by FISH. J Assist Reprod Genet (1996) 1.19